There is a small chance that Pfizer’s vaccine trial will yield results by Nov. 3. But it could still take weeks for FDA review. Here’s everything that has to happen and how to tell a political stunt from a real vaccine.
by Caroline Chen, Isaac Arnsdorf and Ryan Gabrielson
In the early days of the coronavirus pandemic when testing supplies were limited, local politicians went to great lengths to help a businessman with a criminal past try to sell telehealth and COVID-19 services across Texas. This is their story.
by Vianna Davila, Jeremy Schwartz and Lexi Churchill
The malware attack, which sent fake email replies to voters and businesses, spotlights an overlooked vulnerability in counties that don’t follow best practices for computer security.
by Jack Gillum, Jessica Huseman, Jeff Kao and Derek Willis
After Black union workers petitioned the state for more secure ballot drop boxes, top election officials called Hans von Spakovsky, a leading purveyor of discredited voting fraud claims, and then put a strict limit on the boxes instead.
Black voters were more than twice as likely to have mail-in ballots rejected than those submitted by the state’s white voters in 2018, and rejection rates for 2020 show a similar pattern, according to a new analysis by ProPublica and WRAL News.
by Sophie Chou, ProPublica, and Tyler Dukes, WRAL News
The administration calls Moncef Slaoui, who leads its vaccine race, a “contractor” to sidestep rules against personally profiting from government positions. Slaoui owns $10 million in stock of a company working with his team to develop a vaccine.
New Jersey officers accused of violence, sexual misconduct and more have walked free in deals that dodge a tough sentencing law. Now lawmakers want to eliminate it.
Ronnie Rollins used a controversial loophole to secure $300 million in bonus payments for his nonprofit nursing home chain. A federal investigation called the payments “inappropriate,” and Georgia is caught in a multimillion dollar dispute.
Was this email forwarded to you from a friend?
Subscribe.
This email was sent to [email protected]. Update your
email preferences or unsubscribe
to stop receiving this newsletter. Email not displaying correctly?
View it in your browser.